The gesture life of high mobility group box 1

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 6, Issue 3, 2003, Pages 283-287

  Friedman, Steven G ^a,b   Czura, Christopher J ^b   Tracey, Kevin J ^b  

^a NORTH SHORE UNIVERSITY HOSPITAL   (United States)

^b North Shore Long Island Jewish Research Institute ^*  (United States)

Author keywords

Cytokines; HMGB1; Inflammation; Macrophages; Sepsis

Indexed keywords

CYTOKINE; DNA BINDING PROTEIN; ENDOTOXIN; HIGH MOBILITY GROUP B1 PROTEIN; INTERLEUKIN 1BETA; PROTEIN INHIBITOR; TUMOR NECROSIS FACTOR; RECOMBINANT PROTEIN;

ACUTE LUNG INJURY; ANIMAL EXPERIMENT; ANIMAL MODEL; INFLAMMATION; INTESTINE INJURY; METASTASIS; NONHUMAN; PROTEIN DOMAIN; REVIEW; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; ANIMAL; BLOOD; DRUG ANTAGONISM; HUMAN; NEOPLASM; PATHOLOGY; PHYSIOLOGY;

ANIMALIA;

ANIMALS; CYTOKINES; DNA-BINDING PROTEINS; HMGB1 PROTEIN; HUMANS; INFLAMMATION; NEOPLASMS; RECOMBINANT PROTEINS;

EID: 0037589850     PISSN: 13631950     EISSN: None     Source Type: Journal    
DOI: 10.1097/00075197-200305000-00003     Document Type: Review

References (34)

1. Lee C-R. A gesture life. New York: Riverhead Books; 1999.
2. Jones EW, editor. The HMG chromosomal proteins. London: Academic Press; 1985.
3. Bustin M. Revised nomenclature for high mobility group (HMG) chromosomal proteins. Trends Biochem Sci 2001; 26:152-153.
4. Bustin M, Reeves R. High-mobility-group chromosomal proteins: architectural components that facilitate chromatin function. Prog Nucleic Acid Res Mol Biol 1996; 54:35-100.
5. Czura CJ, Wang H, Tracey KJ. Dual roles for HMGB1: DNA binding and cytokine. J Endotoxin Res 2001; 7:315-321.
6. Czura CJ, Tracey KJ. Targeting high mobility group box 1 as a late-acting mediator of inflammation. Crit Care Med 2003; 31:S46-S50.
7. Calogero S, Grassi F, Aguzzi A, et al. The lack of chromosomal protein Hmg1 does not disrupt cell growth but causes lethal hypoglycaemia in newborn mice. Nat Genet 1999; 22:276-280.
8. Rauvala H, Pihlaskari R. Isolation and some characteristics of an adhesive factor of brain that enhances neurite outgrowth in central neurons. J Biol Chem 1987; 262:16625-16635.
9. Daston MM, Ratner N. Expression of P30, a protein with adhesive properties, in Schwann cells and neurons of the developing and regenerating peripheral nerve. J Cell Biol 1991; 112:1229-1239.
10. Schmidt AM, Yan SD, Yan SF, Stern DM. The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. J Clin Invest 2001; 108:949-955.
11. Parkkinen J, Raulo E, Merenmies J, et al. Amphoterin, the 30-kDa protein in a family of HMG1-type polypeptides. Enhanced expression in transformed cells, leading edge localization, and interactions with plasminogen activation. J Biol Chem 1993; 268:19726-19738.
12. Parkkinen J, Rauvala H. Interactions of plasminogen and tissue plasminogen activator (t-PA) with amphoterin. Enhancement of t-PA-catalyzed plasminogen activation by amphoterin. J Biol Chem 1991; 266:16730-16735.
13. Bernard GR, Vincent JL, Laterre PF, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001; 344:699-709.
14. Taguchi A, Blood DC, del Toro G, et al. Blockade of RAGE-amphoterin signalling suppresses tumor growth and metastases. Nature 2000; 405:354-360.
15. Huttunen HJ, Fages C, Rauvala H. Receptor for advanced glycation end products (RAGE)-mediated neurite outgrowth and activation of NF-kappaB require the cytoplasmic domain of the receptor but different downstream signaling pathways. J Biol Chem 1999; 274:19919-19924.
16. Huttunen HJ, Fages C, Kuja-Panula J, et al. Receptor for advanced glycation end products-binding COOH-terminal motif of amphoterin inhibits invasive migration and metastasis. Cancer Res 2002; 62:4805-4811.
17. Wang H, Yang H, Czura CJ, et al. HMGB1 as a late mediator of lethal systemic inflammation. Am J Respir Crit Care Med 2001; 164:1768-1773.
18. Wang H, Bloom O, Zhang M, et al. HMG-1 as a late mediator of endotoxin lethality in mice. Science 1999; 285:248-251.
19. Wang H, Vishnubhakat JM, Bloom O, et al. Proinflammatory cytokines (tumor necrosis factor and interleukin 1) stimulate release of high mobility group protein-1 by pituicytes. Surgery 1999; 126:389-392.
20. Gardella S, Andrei C, Ferrera D, et al. The nuclear protein HMGB1 is secreted by monocytes via a non-classical, vesicle-mediated secretory pathway. EMBO Rep 2002; 3:995-1001.
21. Nathan CF. Secretory products of macrophages. J Clin Invest 1987; 79:319-326.
22. Andersson U, Wang H, Palmblad K, et al. High mobility group 1 protein (HMG-1) stimulates proinflammatory cytokine synthesis in human monocytes. J Exp Med 2000; 192:565-570.
23. Li J, Kokkola R, Tabibzadeh S, et al. Structural basis for the pro-inflammatory cytokine activity of high mobility group box 1 (HMGB1). Mol Med (in press).
24. Abraham E, Arcaroli J, Carmody A, et al. HMG-1 as a mediator of acute lung inflammation. J Immunol 2000; 165:2950-2954.
25. Sappington PL, Yang R, Yang H, et al. HMGB1 B box increases the permeability of Caco-2 enterocytic monolayers and impairs intestinal barrier function in mice. Gastroenterology 2002; 123:790-802. This study demonstrated that HMGB1 disrupts intestinal barrier function, providing a potential physiologic mechanism of action of HMGB1 in systemic inflammation.
26. Agnello D, Wang H, Yang H, et al. HMGB-1, a DNA-binding protein with cytokine activity, induces brain TNF and IL-6 production, and mediates anorexia and taste aversion. Cytokine 2002 21; 18:231-236.
27. Fink MP. Reactive oxygen species as mediators of organ dysfunction caused by sepsis, acute respiratory distress syndrome, or hemorrhagic shock: potential benefits of resuscitation with Ringer's ethyl pyruvate solution. Curr Opin Clin Nutr Metab Care 2002; 5:167-174.
28. Ulloa L, Ocnani M, Yang H, et al. Ethyl pyruvate prevents lethality in mice with established lethal sepsis and systemic inflammation. Proc Natl Acad Sci USA 2002; 99:12351-12356.
29. Ombrellino M, Wang H, Ajemian MS, et al. Increased serum concentrations of high-mobility-group protein 1 in haemorrhagic shock. Lancet 1999; 354:1446-1447.
30. Kokkola R, Sundberg E, Ulfgren AK, et al. High mobility group box chromosomal protein 1: a novel proinflammatory mediator in synovitis. Arthritis Rheum 2002; 46:2598-2603. The authors demonstrated a role for HMGB1 in human and experimental localized, chronic inflammation (arthritis).
31. Scaffidi P, Misteli T, Bianchi ME. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 2002; 418:191-195. This study demonstrated that HMGB1 is an essential component of the proinflammatory effects of necrotic cells.
32. Bustin M. At the crossroads of necrosis and apoptosis: signaling to multiple cellular targets by HMGB1. Sci STKE 2002; 2002:PE39. This is a recent comprehensive review of HMGB1 extracellular activity, and its potential role as an extracellular 'danger' signal.
33. Yang H, Wang H, Tracey KJ. HMG-1 rediscovered as a cytokine. Shock 2001; 15:247-253.
34. Zetterstrom CK, Bergman T, Rynnel-Dagoo B, et al. High mobility group box chromosomal protein 1 (HMGB1) is an antibacterial factor produced by the human adenoid. Pediatr Res 2002; 52:148-154.